Dexcom | DXCM
Stock Price
77.96
Daily Change
-0.04 -0.05%
Monthly
8.01%
Yearly
-31.60%
Q4 Forecast
68.15


Peers Price Chg Day Year Date
Abbott 117.96 -0.24 -0.20% 14.85% Nov/26
Align Technology 227.76 -13.15 -5.46% 5.08% Nov/26
AtriCure 35.79 -0.22 -0.61% -14.79% Nov/26
Avanos Medical 19.16 -0.21 -1.08% -10.80% Nov/26
Baxter International 32.85 -0.66 -1.96% -9.82% Nov/26
Becton, Dickinson and Co. 224.25 -1.32 -0.59% -6.12% Nov/26
Boston Scientific 90.21 0.95 1.07% 61.98% Nov/26
Cooper Companies 102.65 0.19 0.19% 22.61% Nov/26
Dexcom 77.96 -0.04 -0.05% -31.60% Nov/26
Edwards Lifesciences 71.56 0.32 0.45% 6.55% Nov/26
Globus Medical 84.53 0.04 0.05% 83.48% Nov/26
Hologic 79.00 -0.73 -0.92% 10.44% Nov/26
Integra LifeSciences 23.70 -0.54 -2.23% -38.73% Nov/26
J&J 154.37 -1.38 -0.89% 2.04% Nov/26
Masimo 172.26 -5.44 -3.06% 80.79% Nov/26
Medtronic 85.92 -0.07 -0.08% 8.76% Nov/26
Merit Medical Systems 104.00 -0.92 -0.88% 44.91% Nov/26
Insulet 266.42 -0.16 -0.06% 41.91% Nov/26
Roche Holding 251.40 -2.10 -0.83% 6.12% Nov/26
Stryker 389.57 4.80 1.25% 32.52% Nov/26
Teleflex 191.03 -3.04 -1.57% -12.71% Nov/26
Tandem Diabetes Care 30.04 -0.38 -1.25% 54.29% Nov/26
West Pharmaceutical Services 319.20 -0.18 -0.06% -9.81% Nov/26
Zimmer Biomet Holdings 110.64 -0.32 -0.29% -2.81% Nov/26

Indexes Price Day Year Date
USND 19174 119.46 0.63% 34.64% Nov/26
US2000 2424 -17.72 -0.73% 34.60% Nov/26
US500 6023 34.27 0.57% 32.23% Nov/27
US100 20914 118.01 0.57% 30.63% Nov/27

Dexcom traded at $77.96 this Tuesday November 26th, decreasing $0.04 or 0.05 percent since the previous trading session. Looking back, over the last four weeks, Dexcom lost 8.01 percent. Over the last 12 months, its price fell by 31.60 percent. Looking ahead, we forecast Dexcom to be priced at 68.15 by the end of this quarter and at 65.66 in one year, according to Trading Economics global macro models projections and analysts expectations.

Dexcom, Inc. is a medical device company. The Company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and by healthcare providers. Its products include Dexcom G6 and Dexcom Share. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on the patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients, who can remotely monitor a patient’s glucose information and receive alert notifications.